Betty L. Goon

702 total citations
8 papers, 551 citations indexed

About

Betty L. Goon is a scholar working on Hematology, Hepatology and Genetics. According to data from OpenAlex, Betty L. Goon has authored 8 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 4 papers in Hepatology and 2 papers in Genetics. Recurrent topics in Betty L. Goon's work include Erythropoietin and Anemia Treatment (4 papers), Hepatitis C virus research (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Betty L. Goon is often cited by papers focused on Erythropoietin and Anemia Treatment (4 papers), Hepatitis C virus research (4 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Betty L. Goon collaborates with scholars based in United States, Belgium and Italy. Betty L. Goon's co-authors include Peter Bowers, Paul J. Pockros, Douglas T. Dieterich, Teresa L. Wright, Nezam H. Afdhal, Mitchell L. Shiffman, Zobair M. Younossi, Eugene R. Schiff, Mary C. Wacholtz and Mary Guilfoyle and has published in prestigious journals such as Gastroenterology, Hepatology and The Lancet Oncology.

In The Last Decade

Betty L. Goon

8 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Betty L. Goon United States	6	362	301	187	69	46	8	551
Hae-Young Kim United States	9	404 1.1×	411 1.4×	105 0.6×	133 1.9×	32 0.7×	10	735
Jhon Prieto United States	10	140 0.4×	159 0.5×	181 1.0×	115 1.7×	25 0.5×	22	510
Nigel Heaton United Kingdom	14	299 0.8×	229 0.8×	52 0.3×	64 0.9×	47 1.0×	29	559
Martina Wichlas Austria	6	235 0.6×	172 0.6×	182 1.0×	47 0.7×	25 0.5×	13	393
Silvia Oldani Italy	12	202 0.6×	204 0.7×	50 0.3×	41 0.6×	44 1.0×	25	870
Themistoklis Vassiliadis Greece	17	371 1.0×	427 1.4×	34 0.2×	35 0.5×	22 0.5×	28	657
Laure Devers France	6	135 0.4×	188 0.6×	249 1.3×	39 0.6×	11 0.2×	6	517
Roman Perri United States	13	361 1.0×	238 0.8×	51 0.3×	14 0.2×	15 0.3×	20	605
Antonio Linares Spain	8	523 1.4×	521 1.7×	42 0.2×	27 0.4×	28 0.6×	10	766
Woei-Yau Kao Taiwan	9	258 0.7×	311 1.0×	57 0.3×	39 0.6×	32 0.7×	18	517

Countries citing papers authored by Betty L. Goon

Since Specialization

Citations

This map shows the geographic impact of Betty L. Goon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betty L. Goon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betty L. Goon more than expected).

Fields of papers citing papers by Betty L. Goon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betty L. Goon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betty L. Goon. The network helps show where Betty L. Goon may publish in the future.

Co-authorship network of co-authors of Betty L. Goon

This figure shows the co-authorship network connecting the top 25 collaborators of Betty L. Goon. A scholar is included among the top collaborators of Betty L. Goon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betty L. Goon. Betty L. Goon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Sternberg, Cora N., Daniel Castellano, Gedske Daugaard, et al.. (2014). Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial. The Lancet Oncology. 15(11). 1263–1268. 40 indexed citations

Castellano, Daniel, Sergio Bracarda, Marcello Tucci, et al.. (2014). Analysis of European Patients Enrolled in a Global Early Access Protocol with Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer Progressing After Chemotherapy. Annals of Oncology. 25. iv269–iv269. 1 indexed citations

Balan, Vijayan, David H. Schwartz, George Y. Wu, et al.. (2005). Erythropoietic Response to Anemia in Chronic Hepatitis C Patients Receiving Combination Pegylated Interferon/Ribavirin. The American Journal of Gastroenterology. 100(2). 299–307. 49 indexed citations

Pockros, Paul J., Mitchell L. Shiffman, Eugene R. Schiff, et al.. (2004). Epoetin Alfa Improves Quality of Life in Anemic Hcv–Infected Patients Receiving Combination Therapy. Hepatology. 40(6). 1450–1458. 116 indexed citations

Afdhal, Nezam H., Douglas T. Dieterich, Paul J. Pockros, et al.. (2004). Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study1 1The other PROACTIVE Study Group investigators included the following: Vijayan Balan, M.D., Mayo Clinic Scottsdale, Scottsdale, Arizona; Norbert Bräu, M.D., Bronx VA Medical Center, Bronx, New York; Robert Brown, M.D., M.P.H., NY Presbyterian Medical Center, New York, New York; William Carey, M.D., Cleveland Clinic Foundation, Cleveland, Ohio; Andrea Duchini, M.D., Baylor College of Medicine, Houston, Texas; Greg Everson, M.D., University of Colorado Health Sciences Center, Denver, Colorado; Michael Fried, M.D., University of North Carolina, Chapel Hill, North Carolina; Robert Gish, M.D., California Pacific Medical Center, San Francisco, California; Ira Jacobson, M.D., Weill Medical College of Cornell University, New York, New York; John W. King, LSU Health Sciences Center, Shreveport, LA; Raymond Koff, M.D., University of Massachusetts Memorial Health Care, Worcester, Massachusetts; William Lee, M.D., University of Texas Southwestern Medical Center, Dallas, Texas; Mark A. Levstik, M.D., The University of Tennessee, Memphis, Tennessee; John G. McHutchison, M.D., Scripps Clinic, La Jolla, California; Marion Peters, M.D., University of California San Francisco, San Francisco, California; Kenneth Sherman, M.D., Ph.D., University of Cincinnati College of Medicine, Cincinnati, Ohio; Coleman Smith, M.D., Minnesota Clinical Research Center, St. Paul, MN; Ronald Wasserman, M.D., Hepatitis Resource Center, Walnut Creek, California.. Gastroenterology. 126(5). 1302–1311. 232 indexed citations

Goon, Betty L., et al.. (2003). Once-Weekly Epoetin Alfa Dosing Is as Effective as Three Times–Weekly Dosing in Increasing Hemoglobin Levels and Is Associated With Improved Quality of Life in Anemic HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(4). 368–378. 24 indexed citations

Goon, Betty L., et al.. (2003). 306 Epoetin alfa (EPO) improves and maintains health-related quality of life (HRQL) in anemic HCV-infected patients receiving interferon/ribavirin (IFN/RBV): HRQL results from the proactive study. Hepatology. 38. 302–303. 3 indexed citations

Cheung, Wing K., Betty L. Goon, Mary Guilfoyle, & Mary C. Wacholtz. (1998). Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects*. Clinical Pharmacology & Therapeutics. 64(4). 412–423. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact